Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
Authors
Keywords
-
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 237, Issue -, Pages 108172
Publisher
Elsevier BV
Online
2022-03-16
DOI
10.1016/j.pharmthera.2022.108172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Icosapent Ethyl for Primary Versus Secondary Prevention of Major Adverse Cardiovascular Events in Hypertriglyceridemia-Value for Money Analysis
- (2021) Ronen Arbel et al. AMERICAN JOURNAL OF MEDICINE
- Triglycerides and risk of atherosclerotic cardiovascular disease: An update
- (2021) Michel Farnier et al. Archives of Cardiovascular Diseases
- Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force
- (2021) Maurizio Averna et al. ATHEROSCLEROSIS
- Cardiovascular effects of omega-3 fatty acids: Hope or hype?
- (2021) Sang-Ho Jo et al. ATHEROSCLEROSIS
- The changing landscape of atherosclerosis
- (2021) Peter Libby NATURE
- EPA’s pleiotropic mechanisms of action: a narrative review
- (2021) John R. Nelson et al. POSTGRADUATE MEDICINE
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- (2021) Frank L J Visseren et al. EUROPEAN HEART JOURNAL
- A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs
- (2021) Takahito Doi et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
- (2021) Henry N Ginsberg et al. EUROPEAN HEART JOURNAL
- Triglycerides and Residual Atherosclerotic Risk
- (2021) Sergio Raposeiras-Roubin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
- (2021) Salim S. Virani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl
- (2021) Ph Gabriel Steg et al. EUROPEAN HEART JOURNAL
- Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence
- (2020) Samuel C.R. Sherratt et al. CURRENT OPINION IN LIPIDOLOGY
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction
- (2020) Zanfina Ademi et al. European Journal of Preventive Cardiology
- Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
- (2020) R. Preston Mason et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study
- (2020) Morten Kaltoft et al. EUROPEAN HEART JOURNAL
- Improving Risk Assessment in the European Food Safety Authority: Lessons From the European Medicines Agency
- (2020) Sevasti Chatzopoulou et al. Frontiers in Plant Science
- Causes and Consequences of Hypertriglyceridemia
- (2020) Chris J. Packard et al. Frontiers in Endocrinology
- Applicability of the REDUCE‐IT trial to the FAST‐MI registry. Are the results of randomized trials relevant in routine clinical practice?
- (2020) Jean Ferrières et al. CLINICAL CARDIOLOGY
- Remnant lipoproteins
- (2020) Carlos A. Aguilar Salinas et al. CURRENT OPINION IN LIPIDOLOGY
- Effects of Fatty Acid Therapy in Addition to Strong Statin on Coronary Plaques in Acute Coronary Syndrome: An Optical Coherence Tomography Study
- (2020) Yoko Kita et al. Journal of the American Heart Association
- The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular Disease
- (2020) Patricia G. Synnott et al. Journal of Managed Care & Specialty Pharmacy
- Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction
- (2020) Alberto Zambon et al. Current Atherosclerosis Reports
- Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial
- (2020) Matthew J Budoff et al. EUROPEAN HEART JOURNAL
- Reduction in Revascularization With Icosapent Ethyl
- (2020) Benjamin E. Peterson et al. CIRCULATION
- Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial
- (2020) Are Annesønn Kalstad et al. CIRCULATION
- Inflammation in Atherosclerosis—No Longer a Theory
- (2020) Peter Libby CLINICAL CHEMISTRY
- Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events
- (2020) Garima Sharma et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- (2020) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation
- (2020) Stefania Lamon-Fava et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- PCV55 Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada.
- (2020) J. Lachaine et al. VALUE IN HEALTH
- Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells
- (2019) Kembra Albracht-Schulte et al. Nutrients
- Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
- (2019) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease
- (2019) Fabien Picard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incidence, factors, and clinical significance of cholesterol crystals in coronary plaque: An optical coherence tomography study
- (2019) Kazuhiro Fujiyoshi et al. ATHEROSCLEROSIS
- Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
- (2019) Guy De Backer et al. ATHEROSCLEROSIS
- The cost-effectiveness of omega-3 polyunsaturated fatty acids – The Australian healthcare perspective
- (2019) Lan Gao et al. European Journal of Internal Medicine
- The Economic Burden of Hypertriglyceridemia Among US Adults With Diabetes or Atherosclerotic Cardiovascular Disease on Statin Therapy
- (2019) Brian C. Case et al. Journal of Clinical Lipidology
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles
- (2019) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients
- (2019) Peter P. Toth et al. MAYO CLINIC PROCEEDINGS
- Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
- (2019) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Clinical review on triglycerides
- (2019) Ulrich Laufs et al. EUROPEAN HEART JOURNAL
- Body mass index, triglycerides and risk of acute pancreatitis: A population-based study of 118,000 individuals
- (2019) Signe E J Hansen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Understanding why REDUCE-IT was positive – Mechanistic overview of eicosapentaenoic acid
- (2019) William S. Harris PROGRESS IN CARDIOVASCULAR DISEASES
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
- (2019) Michel R. Langlois et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- European Society of Cardiology: Cardiovascular Disease Statistics 2019
- (2019) Adam Timmis et al. EUROPEAN HEART JOURNAL
- Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin
- (2018) R. Preston Mason et al. BIOMEDICINE & PHARMACOTHERAPY
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
- (2018) Om P. Ganda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
- (2018) Anum Saeed et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children
- (2018) Melinda H. Spooner et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
- (2018) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Monocyte-Macrophages and T Cells in Atherosclerosis
- (2017) Ira Tabas et al. IMMUNITY
- A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins
- (2017) Tetsu Watanabe et al. Journal of Cardiology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease
- (2016) Matthew Budoff AMERICAN JOURNAL OF CARDIOLOGY
- Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies
- (2016) Christie M. Ballantyne et al. ATHEROSCLEROSIS
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
- (2016) Melody G. Duvall et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism
- (2015) Arthur A. Spector et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability
- (2015) Christian Erbel et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Changes in transcriptome of macrophages in atherosclerosis
- (2015) Dimitry A. Chistiakov et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins
- (2015) Gregory G. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA
- (2015) Benjamin B. Albert et al. Scientific Reports
- Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma
- (2014) Ryo Nishio et al. ATHEROSCLEROSIS
- Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study
- (2014) Maria-Agata Miselli et al. Cardiovascular Diabetology
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
- (2013) Scott M. Grundy et al. ATHEROSCLEROSIS
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
- (2013) Scott M. Grundy et al. Journal of Clinical Lipidology
- n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
- (2012) Anders Berg Jørgensen et al. EUROPEAN HEART JOURNAL
- French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010
- (2012) Michel Hanssen et al. HEART
- Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)
- (2012) Harold E. Bays et al. Journal of Clinical Lipidology
- Macrophage Differentiation and Function in Atherosclerosis: Opportunities for Therapeutic Intervention?
- (2012) Howell J. Williams et al. Journal of Innate Immunity
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Hypertriglyceridemia secondary to obesity and diabetes
- (2011) Savitha Subramanian et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Relationship Between Coronary Plaque Vulnerability and Serum n-3/n-6 Polyunsaturated Fatty Acid Ratio
- (2011) Toshikazu Kashiyama et al. CIRCULATION JOURNAL
- Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
- (2011) Uchechukwu K. Sampson et al. Current Atherosclerosis Reports
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Add-on Therapy of EPA Reduces Oxidative Stress and Inhibits the Progression of Aortic Stiffness in Patients with Coronary Artery Disease and Statin Therapy: A Randomized Controlled Study
- (2011) Akira Takaki et al. Journal of Atherosclerosis and Thrombosis
- OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction
- (2010) Bernhard Rauch et al. CIRCULATION
- n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
- (2010) Daan Kromhout et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial
- (2008) Michael Miller et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started